Minghua Ji

1.0k total citations
18 papers, 887 citations indexed

About

Minghua Ji is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Minghua Ji has authored 18 papers receiving a total of 887 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Minghua Ji's work include MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (4 papers) and Extracellular vesicles in disease (2 papers). Minghua Ji is often cited by papers focused on MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (4 papers) and Extracellular vesicles in disease (2 papers). Minghua Ji collaborates with scholars based in China, United States and Israel. Minghua Ji's co-authors include Jinhai Tang, Jian Wu, Jianhua Zhao, Shanliang Zhong, Luo Zhou, Mengmeng Lv, Wei‐xian Chen, Lin Chen, Xuemin Liu and Qing Hu and has published in prestigious journals such as PLoS ONE, Medicine and Cancer Biology & Therapy.

In The Last Decade

Minghua Ji

18 papers receiving 874 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minghua Ji China 13 679 551 183 57 56 18 887
Mayumi Tamada Japan 5 450 0.7× 321 0.6× 219 1.2× 46 0.8× 52 0.9× 5 653
Binlu Huang China 7 590 0.9× 403 0.7× 133 0.7× 109 1.9× 116 2.1× 7 942
Cassandra L. Hodgkinson United Kingdom 13 504 0.7× 433 0.8× 368 2.0× 56 1.0× 102 1.8× 14 870
Jinfu Yang United States 6 766 1.1× 661 1.2× 209 1.1× 85 1.5× 67 1.2× 12 1.1k
Phuong Nguyen United States 7 532 0.8× 354 0.6× 159 0.9× 43 0.8× 129 2.3× 10 728
Jessica A. Beach United States 13 552 0.8× 325 0.6× 336 1.8× 94 1.6× 112 2.0× 21 903
Mazvita Maziveyi United States 7 588 0.9× 280 0.5× 261 1.4× 57 1.0× 89 1.6× 9 858
Jia Min Loo Singapore 9 461 0.7× 292 0.5× 176 1.0× 61 1.1× 51 0.9× 14 689
Aoife Ward Germany 14 966 1.4× 796 1.4× 194 1.1× 80 1.4× 81 1.4× 21 1.2k
Songbing He China 20 736 1.1× 519 0.9× 194 1.1× 61 1.1× 112 2.0× 34 957

Countries citing papers authored by Minghua Ji

Since Specialization
Citations

This map shows the geographic impact of Minghua Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minghua Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minghua Ji more than expected).

Fields of papers citing papers by Minghua Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minghua Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minghua Ji. The network helps show where Minghua Ji may publish in the future.

Co-authorship network of co-authors of Minghua Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Minghua Ji. A scholar is included among the top collaborators of Minghua Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minghua Ji. Minghua Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ji, Minghua, et al.. (2024). USP36 regulates the proliferation, survival, and differentiation of hFOB1.19 osteoblast. Journal of Orthopaedic Surgery and Research. 19(1). 483–483. 2 indexed citations
3.
Zhao, Jing, Peng Zhang, Jianhua Wang, et al.. (2017). Plasma levels of soluble programmed death ligand-1 may be associated with overall survival in nonsmall cell lung cancer patients receiving thoracic radiotherapy. Medicine. 96(7). e6102–e6102. 36 indexed citations
4.
Wang, Jiangnan, Rong Ma, Ashok Sharma, et al.. (2015). Inflammatory Serum Proteins Are Severely Altered in Metastatic Gastric Adenocarcinoma Patients from the Chinese Population. PLoS ONE. 10(4). e0123985–e0123985. 10 indexed citations
5.
Wu, Xiaoqing, Minghua Ji, Qingling Wang, et al.. (2015). Midkine as a potential diagnostic marker in epithelial ovarian cancer for cisplatin/paclitaxel combination clinical therapy.. PubMed. 5(2). 629–38. 21 indexed citations
6.
Zhu, Ying, Changfei Mao, Jian Wu, et al.. (2014). Improved ataxia telangiectasia mutated kinase inhibitor KU60019 provides a promising treatment strategy for non-invasive breast cancer. Oncology Letters. 8(5). 2043–2048. 14 indexed citations
7.
Lv, Min, Yan Li, Minghua Ji, Ming Zhuang, & Jinhai Tang. (2014). Inhibition of invasion and epithelial-mesenchymal transition of human breast cancer cells by hydrogen sulfide through decreased phospho-p38 expression. Molecular Medicine Reports. 10(1). 341–346. 41 indexed citations
8.
Chen, Wei‐xian, Xuemin Liu, Mengmeng Lv, et al.. (2014). Exosomes from Drug-Resistant Breast Cancer Cells Transmit Chemoresistance by a Horizontal Transfer of MicroRNAs. PLoS ONE. 9(4). e95240–e95240. 360 indexed citations
9.
Zhu, Ying, Jian Wu, Shuchun Li, et al.. (2013). The Function Role of miR-181a in Chemosensitivity to Adriamycin by Targeting Bcl-2 in Low-Invasive Breast Cancer Cells. Cellular Physiology and Biochemistry. 32(5). 1225–1237. 67 indexed citations
10.
Zhu, Liwei, Xue Song, Jinhai Tang, et al.. (2013). Huntingtin-associated protein 1: A potential biomarker of breast cancer. Oncology Reports. 29(5). 1881–1887. 15 indexed citations
11.
Qiao, Enqi, Minghua Ji, Jian Wu, et al.. (2013). Expression of the PXR gene in various types of cancer and drug resistance. Oncology Letters. 5(4). 1093–1100. 60 indexed citations
12.
Chen, Wei‐xian, Shanliang Zhong, Minghua Ji, et al.. (2013). MicroRNAs delivered by extracellular vesicles: an emerging resistance mechanism for breast cancer. Tumor Biology. 35(4). 2883–2892. 51 indexed citations
13.
Wu, Jian, Minghua Ji, Tao Ma, et al.. (2013). miR-342 is associated with estrogen receptor-α expression and response to tamoxifen in breast cancer. Experimental and Therapeutic Medicine. 5(3). 813–818. 59 indexed citations
14.
Qiao, Enqi, Minghua Ji, Jian Wu, et al.. (2013). Joint detection of multiple immunohistochemical indices and clinical significance in breast cancer. Molecular and Clinical Oncology. 1(4). 703–710. 11 indexed citations
15.
Li, Jian, Jianwei Qin, Jianhua Zhao, et al.. (2013). Inflammatory Myofibroblastic Tumor of the Breast Coexisting with Breast Cancer: A Case Report. Breast Care. 8(4). 290–292. 12 indexed citations
16.
Ji, Minghua, Jinhai Tang, Jianhua Zhao, et al.. (2012). Polymorphisms in genes involved in drug detoxification and clinical outcomes of anthracycline-based neoadjuvant chemotherapy in Chinese Han breast cancer patients. Cancer Biology & Therapy. 13(5). 264–271. 36 indexed citations
17.
Li, Xiujuan, Minghua Ji, Shanliang Zhong, et al.. (2012). MicroRNA-34a Modulates Chemosensitivity of Breast Cancer Cells to Adriamycin by Targeting Notch1. Archives of Medical Research. 43(7). 514–521. 85 indexed citations
18.
Chi, Alexander, Nam P. Nguyen, Jiahong Xu, et al.. (2012). Correlation of Three Different Approaches of Small Bowel Delineation and Acute Lower Gastrointestinal Toxicity in Adjuvant Pelvic Intensity-Modulated Radiation Therapy for Endometrial Cancer. Technology in Cancer Research & Treatment. 11(4). 353–359. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026